Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to drugsafety@propharmagroup.com OR Product Complaint to productcomplaint@propharmagroup.com, OR medical information request to MedInfo@propharmagroup.com.
New and Improved

Calcium Gluconate in Sodium Chloride Injection

Therapeutic Category: Electrolyte Replenisher

FDA APPROVED READY TO USE BAGS

1,000 mg per 50 mL in a 100 mL Single-Dose Bag
2,000 mg per 100 mL in a 100 mL Single-Dose Bag

  • REDUCED WASTE
    Now with 36-month shelf life at controlled room temperature storage
  • STOCK MORE BAGS IN THE AUTOMATIC DISPENSING CABINET
    with 60 days stability outside the overwrap
  • AS ALWAYS DEHP AND PVC FREE
    Bag and bag ports are free of Natural Rubber Latex, DEHP and PVC1


Saves time, increases efficiency with no need to compound

To order WGCC products, please contact your wholesaler or call Customer Service at 1-888-493-0861.


NDC# Total Amount Fill Volume Concentration Container Type Pack Size Package Insert Barcodes
44567-620-24 1,000 mg 50 mL 20 mg/mL 100 mL Premix Bag 24 Bag Carton
44567-621-24 2,000 mg 100 mL 20 mg/mL 100 mL Premix Bag 24 Bag Carton

INDICATIONS AND USAGE:

Calcium Gluconate in Sodium Chloride Injection is a form of calcium indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use: The safety of Calcium Gluconate Injection for long term use has not been established. 

IMPORTANT SAFETY INFORMATION:

Contraindicated in hypercalcemia and in neonates receiving ceftriaxone. Warnings and Precautions: cardiac arrhythmias may occur with concomitant cardiac glycoside use; use caution when administering with ceftriaxone as a precipitate may form in the IV line; tissue necrosis and calcinosis may occur with or without extravasation; hypotension, bradycardia and cardiac arrhythmias may occur with rapid administration; contains aluminum which may cause toxicity. The most common adverse events are local soft tissue inflammation and necrosis; calcinosis cutis and calcification related to extravasation; vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmia, syncope and cardiac arrest.

See package insert for complete prescribing information.

References:

  1. CALCIUM GLUCONATE IN SODIUM CHLORIDE Injection [package insert]  2. On file WG Critical Care, LLC

U.S. Patent Number: 10, 130, 646

WG Critical Care Product Catalog

To order WGCC products, please contact your wholesaler or call Customer Service at 1-888-493-0861.
© 2021 WG Critical Care, LLC | A PharmaSphere Company | 120 Rte 17 N, Paramus, NJ 07652